August 20, 2017 2:12 PM ET


Company Overview of QR Pharma, Inc.

Company Overview

QR Pharma, Inc. operates as a specialty pharmaceutical company that develops drugs for treatments for neurological disorders. It develops Posiphen, a drug for the treatment of Alzheimer’s, Parkinson’s, and other neurodegenerative diseases. The company was founded in 2008 and is based in Berwyn, Pennsylvania.

1055 Westlakes Drive

Suite 300

Berwyn, PA 19312

United States

Founded in 2008





Key Executives for QR Pharma, Inc.

Founder, Chief Executive Officer, President and Director
Consulting Chief Financial Officer
Vice President of Formulation
Compensation as of Fiscal Year 2017.

QR Pharma, Inc. Key Developments

QR Pharma, Inc. Announces Advisory Board Appointments

QR Pharma, Inc. announced the appointment of four world-class key opinion leaders to its Scientific Advisory Board (SAB). These new appointments join QR Pharma's previous roster of impressive advisors in order to provide strategic leadership and direction to support the development of the breakthrough mechanism of action of Posiphen in neurodegenerative disease. The four new scientific advisory board members are: William Mobley, M.D., Ph.D., is Distinguished Professor, Department of Neurosciences Florence Riford Chair for Alzheimer Research and Associate Dean for Neurosciences Initiatives. He is a member of the National Academy of Medicine. Gregory Petsko, Ph.D., is the Arthur J. Mahon Professor of Neurology and Neuroscience and Director, Helen and Robert Appel Alzheimer'sDisease Research Institute at Weill Cornell Medical College and adjunct professor of Biomedical Engineering at Cornell University. He is a member of the National Academy of Sciences. Sidney Strickland, Ph.D., is the Vice President and Dean for Educational Affairs and Research Professor, Patricia and John Rosenwald Laboratory of Neurobiology and Genetics at Rockefeller University. Rudolph Tanzi, Ph.D., is Vice-Chair and Director of Neurology, Genetics and Aging, and the Joseph and Rose Kennedy Professor of Neurology at Massachusetts General Hospital. Jeffrey Cummings, MD, Cleveland Clinic, is Director, Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas, Nevada and Cleveland, Ohio. Camille and Larry Ruvo Chair of the Neurological Institute of Cleveland Clinic and Professor of Medicine (Neurology), Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Peter Davies, PhD, is Director of the Litwin-Zucker Research Center for the Study of Alzheimer's Disease, The Feinstein Institute for Medical Research and Professor, Pathology and Neuroscience, at the Hofstra Northwell School of Medicine atHofstra University.

QR Pharma, Inc. Presents at The 23rd Annual NewsMakers in the Biotech Industry Conference, Sep-09-2016

QR Pharma, Inc. Presents at The 23rd Annual NewsMakers in the Biotech Industry Conference, Sep-09-2016. Venue: Millennium Broadway Hotel & Conference Center, New York, New York, United States. Presentation Date(s): Sep-09-2016.

Similar Private Companies By Industry

Company Name Region
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

Private Placement
October 11, 2016

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact QR Pharma, Inc., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at